Hangzhou Zhongmei Huadong Pharm. Co. Ltd.
Our company is a large-scale comprehensive group owning a public stock company (Huadong Medicine Co Ltd), several joint ventures (Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd, Hangzhou MSD Pharmaceutical Co Ltd, Hangzhou Jiuyuan Gene Engineering Co Ltd, Zhejiang Huayi Pharmaceutical Co Ltd and Zhejiang ESTEVE-HUAYI Pharmaceutical Co Ltd) and series of share-holder pharmaceutical and chemical companies.
We are manufacturers of Dosages, APIs and intermediates by fermentation, synthesis and biotechnology, especially in the area of immunosuppressant and anti-diobetic agents. Our main products include: Acarbose, Cyclosporine, Febuxostat, Mycophenolate Mofetil, Orlistat, Sirolimus, Tacrolimus, Everolimus, etc. and series of finishend dosage, including tablets, capsules, injection, oral solution.
|Sales markets||Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America|
|Affiliated categories:||API Contract Manufacturing |Excipients More|
CPhI Worldwide 20195-7 November 2019 Frankfurt, Germany We were at stand 61B13 See our Exhibitor Profile See full Exhibitor List
Our Top products
Hangzhou Zhongmei Huadong Pharmaceutical provides wide range of pharmaceutical products which includes acarbose. It belongs to active pharmaceutical ingredient category. Contact us for more information.More info
Hangzhou Zhongmei Huadong Pharmaceutical provides wide range of pharmaceutical products which includes corbrin capsule. It belongs to formulation category. Functions: nourishes lung and kidney and benefits vital essence. Its effective for the treatment of cough, asthma, chronic kidney trouble, chronic h...More info
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation